RVTY
Revvity·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 2
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About RVTY
Revvity, Inc.
A leading global provider of chromatographs, spectrometers, optical and temperature sensors, and imaging readers
Life Science Tools and Services
--
07/06/1965
New York Stock Exchange
11,000
12-31
Common stock
77 4th Avenue Waltham, Massachusetts 02451
--
Revvity, Inc., was founded in Massachusetts in 1947. The company is a leading provider of health science solutions, technology, expertise and services, providing a complete workflow from discovery to development, from diagnosis to cure. Revvity is revolutionizing the possibilities of healthcare, with specialized focus areas in translational multiomics technology, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics.
Earnings Call
Company Financials
EPS
RVTY has released its 2025 Q3 earnings. EPS was reported at 1.18, versus the expected 1.14, beating expectations. The chart below visualizes how RVTY has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
RVTY has released its 2025 Q3 earnings report, with revenue of 698.95M, reflecting a YoY change of 2.18%, and net profit of 46.65M, showing a YoY change of -50.56%. The Sankey diagram below clearly presents RVTY's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



